The global structural heart devices market is projected to reach USD 15.08 billion by 2023 from USD 9.28 billion in 2018, at a CAGR of 10.2%.
Growth in this market is mainly driven by the rising prevalence of structural heart diseases, regulatory approvals for new and advanced structural heart devices, favorable reimbursement scenario for structural heart procedures & devices, and increasing awareness about structural heart diseases.
Download FREE Brochure @ https://www.marketsandmarkets.com/pdfdownload.asp?id=161123753
The emergence of tissue engineered heart valves, increased adoption of percutaneous interventions such as TAVR, and emerging economies such as China, India, Brazil, and several Middle Eastern countries are expected to offer further growth opportunities for players operating in the market during the forecast period.
On the basis of product, the structural heart devices market is segmented into heart valve devices, occluders and delivery systems, annuloplasty rings, other devices, and accessories. The heart valve devices segment is further divided into transcatheter heart valves and surgical heart valves. The heart valve devices segment is expected to account for the largest share of the structural heart devices market in 2018. The growing number of transcatheter aortic valve replacement procedures performed across the globe, the efficacy and durability of these products, and the growing number of regulatory approvals for heart valve devices are some of the key factors supporting the growth of this product segment.
By procedure, the market has been broadly segmented into replacement procedures and repair procedures. Repair procedures are further segmented into closure procedures, annuloplasty, valvuloplasty, and transcatheter mitral valve repair while replacement procedures are further segmented into transcatheter aortic valve replacement (TAVR) and surgical aortic valve replacement (SAVR). The replacement procedures segment is expected to account for the largest share of the structural heart devices market in 2018. This can be attributed to the long-term durability of these procedures and the widespread preference for transcatheter replacement.
Asia Pacific is expected to register the highest growth rate during the forecast period. The high growth in this region can be attributed to the rising geriatric population, favorable reimbursement scenario, increasing regulatory approvals, the presence of a large target patient population, increasing healthcare expenditure, implementation of government-funded insurance schemes, and the growing medical tourism industry in several APAC countries.
